期刊文献+

脱细胞肝支架的结构和成分对细胞相容性的影响

Effects of structure and composition of decellularized liver biological scaffolds on cytocompatibility
原文传递
导出
摘要 目的 比较不同方法制备脱细胞肝支架(DLBS)的结构和成分以及细胞相容性,探讨其内部联系.方法 取50只成年F344大鼠肝脏,使用文献报道的3种方法[以十二烷基硫酸钠(SDS)、Triton X-100和NP-40为主洗脱剂]制备大鼠DLBS.进行扫描电镜和孔径计算和氨基葡聚糖(GAG)检测.后经门静脉灌注肝卵圆细胞,进行黏附率、增殖情况、免疫荧光、扫描电镜以及白蛋白分泌检测.结果 大体观察、扫描电镜及孔径计算表明NP-40方案细胞外基质较SDS和Triton X-100方案整齐;GAG检测NP-40方案[(44.19±3.35) ng/mg]高于Triton X-100方案[(36.71±2.01) ng/mg]和SDS方案[(21.63 ±2.78) ng/mg];细胞黏附率显示NP-40方案[(95.78±2.11)%]高于SDS方案[(84.18±3.30)%]和Triton X-100方案[(91.15±2.21)%];细胞增殖情况Triton X-100方案和NP-40方案的细胞增殖速度显著高于SDS方案(P<0.05);白蛋白分泌NP-40方案[(85.77±3.30) mg/106个细胞]明显好于SDS方案[(49.37±2.43) mg/106个细胞]和Triton X-100方案[(74.66 ±4.80) mg/106个细胞].结论 DLBS的结构和成分对支架的细胞相容性具有明显的影响,同时也明显观察到NP-40方案较SDS和Triton X-100方案在制备DLBS的优势. Objective To compare the biocompatibility of decellularized liver biological scaffolds (DLBS) made by different methods and discussing the correlation between them.Methods Decellularized liver biological scaffolds were made by transfusing livers of 50 mature F344 rats with three different ways.Glycosaminoglycan (GAG) in the scaffolds was tested,and scanning electron microscope (SCM) and cytotoxicity assays were also used on the scaffolds.The liver oval cells were transfused into scaffolds through the portal vein.Cells on the scaffolds were examined by immunofluorescence (IF),scanning electron microscope,cells adhesion test and albumin excretion detection.Results Scaffolds made by the Method C had better orderliness than other two methods in gross observation,scanning electron microscopy and pore size calculation.The Method C [(44.19 ±3.35) ng/mg] had significantly more GAG than the Method A [(21.63 ±2.78) ng/mg] and Method B [(36.71 ±2.01) ng/mg].The scaffolds made by the Method C [(95.78 ± 2.11) %] had higher collagen than in those made by the Method B [(91.15 ± 2.21) %] and Method A [(84.18 ± 3.30)%].The cell adhesion rate of the Method B and Method C was higher than that of the Method A.Albumin excretion in the Method C [(85.77 ± 3.30) mg/106 cells] was greater than in the Method A [(49.37 ±2.43) mg/106 cells] and Method B [(74.66 ±4.80) mg/106 cells].Conclusion DLBS can be prepared by all three ways,but scaffolds made by our new method have better biocompatibility,and our method has significant advantages over the other methods.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2013年第10期2082-2085,共4页 Chinese Journal of Experimental Surgery
关键词 脱细胞肝支架 组织工程 细胞外基质 卵圆细胞 Decellularized liver scaffolds Tissue engineering Extracellular matrix Hepatic oval cell
  • 相关文献

参考文献21

  • 1曾金华,邱明链,陈丽红,吴燕斌,方航荣,刘景丰.人凋亡相关因子配体及人转化生长因子-β1基因共修饰树突状细胞诱导大鼠肝移植免疫耐受的研究[J].中华实验外科杂志,2011,28(10):1670-1673. 被引量:5
  • 2黄中荣,魏思东,李金政,刘作金,龚建平,余正.大鼠肝移植急性排斥反应中肿瘤坏死因子受体配体的表达及其意义[J].中华实验外科杂志,2011,28(8):1321-1323. 被引量:1
  • 3Vosough M,Moslem M,PoumasrB,et al.Cell-based therapeutics for liver disorders.Br Med Bull,2011,100:157-172.
  • 4Lang R,Stern MM,Smith L,et al.Three-dimensional culture of hepatocytes on porcine liver tissue-derived extracellular matrix.Biomaterials,2011,32:7042-7052.
  • 5Yang B,Zhang Y,Zhou L,et al.Development of a porcine bladder acellular matrix with well-preserved extracellular bioactive factors for tissue engineering.Tissue Eng Part C Methods,2010,16:1201-1211.
  • 6Uygun BE,Soto-Gutierrez A,Yagi H,et al.Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix.Nat Med,2010,16:814-820.
  • 7Baptista PM,Siddiqui MM,Lozier G,et al.The use of whole organ decellularization for the generation of a vascularized liver organoid.Hepatology,2011,53:604-617.
  • 8Ru J,Ning Zhang,Nan You,et al.The differentiation of MSCs into functional hepatocyte-like cells in a liver biomatrix scaffold and their transplantation into liver-fibrotic mice.Biomaterials,2012,33:8995-9008.
  • 9Jungebluth P,Bader A,Baiguera S,et al.The concept of in vivo airway tissue engineering.Biomaterials,2012,33:4319-4326.
  • 10Wainwright JM,Czajka CA,Patel UB,et al.Preparation of cardiac extracellular matrix from an intact porcine heart.Tissue Eng Part C Methods,2010,16:525-532.

二级参考文献23

  • 1张弘炜,史留斌,彭承宏.CD4^+CD25^+T细胞联合CD154单抗抑制大鼠肝移植急性排斥反应的研究[J].中华实验外科杂志,2007,24(2):196-198. 被引量:8
  • 2Fujiki M,Esquivel CO,Martinez OM,et al.Induced tolerance to rat liver allografts involves the apoptosis of intragraft T cells and the generation of CD4(+) CD25(+) FoxP3(+) T regulatory cells.Liver Transpl,2010,16:147-154.
  • 3Chen Y,Yan T,Shi LJ,et al.Knockdown of interleukin-2 by shRNA-mediated RNA interference prolongs liver allograft survival.J Surg Res,2010,159:582-587.
  • 4Liu ZJ,Yan LN,Li XH,et al.Up-Regulation of IRAK-M is essential for endotoxin tolerance induced by a low dose of lipopolysaccharide in kupffer cells.J Surg Res,2008,150:43-49.
  • 5Liao R,Liu Z,Wei S,et al.Triggering receptor in myeloid cells (TREM1) specific expression in peripheral blood mononuclear cells of sepsis patients with acute cholangitis.Inflammation,2009,32:182-190.
  • 6Bae EM,Kim WJ,Suk K,et al.Reverse signaling initiated from GITRL induces NF-kappaB activation through EBK in the inflammatory activation of macrophages.Mul Immunol,2008,45:523-533.
  • 7Sonawane SB,Kim JI,Lee MK,et al.GITR Blockade Facilitates Treg Mediated Allograft Survival.Transplantation,2009,88:1169-1177.
  • 8Rentsch M,Puellmann K,Sirek S,et al.Benefit of Kupffer cell modulation with glycine versus Kupffer cell depletion after liver transplantation in the rat:effects on postischemic reperfusion injury,apoptotic cell death graft regeneration and survival.Transpl Int,2005,18:1079-1089.
  • 9Futagawa Y, Terasaki PI, Waki K, et al. No improvement in long-term liver transplant graft survival in the last decade : an analysis of the UNOS data. Am J Transplant ,2006,6 : 1398-1406.
  • 10Demetris A J, Batts KP, Dhillon AP, et al. Banff schema for grading acute liver alfograft rejection: An international consensus document. Hepatology, 1997,25:658-663.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部